Down Syndrome International is a disabled people's organisation committed to improving the quality of life for people with Down syndrome, promoting their right to be included on a full and equal basis with others.
As part of our COVID-19 response, DSi reached out to organisation members to gather information about access to COVID-19 vaccinations in their country and the barriers encountered and to understand how we can best support them with associated advocacy activities. ∙
The data from this survey was collected from March 11th – April 27th 2021.
∙37 member organisations completed the survey from 35 countries around the world ∙These countries encompassed all world regions (as defined by WHO: Africa, Americas, S-E Asia, Europe, Eastern Mediterranean and Western Pacific)
∙These countries represented and low-, middle- and high-income brackets (as defined by the World Bank)
We found that:
∙Only in 27% of countries were people with Down syndrome, one of the priority groups for vaccination.
∙In 22% of countries, people with Down syndrome are included within another disability group
∙In 46% of countries, people with Down syndrome are being prioritised in the same way as the rest of the population
∙In 5% of countries, people with Down syndrome are being excluded from the vaccination programme.
In response DSi is:
∙liaising with international experts and researchers to provide the latest up-to-date, accurate and evidenced information about COVID-19 vaccines and information to support international, national and regional advocacy efforts.
∙Working with and supporting its member organisations and international partners to advocate for the necessary prioritisation of people with Down syndrome in the COVID-19 vaccination rollout in countries worldwide.
In addition, DSi will publish a COVID-19 advocacy toolkit on the website. ds-int.org
Press release distributed by Pressat on behalf of Down Syndrome International , on Wednesday 2 June, 2021. For more information subscribe and follow https://pressat.co.uk/